Abbott Resumes Baby Formula Production At Michigan PlantAbbott Laboratories Saturday restarted production of a
specialty brand of its infant formula at its Sturgis, Mich., facility after
“meeting initial requirements agreed to with the U.S. Food and Drug Administration,” the company announced.
Though production is beginning, which is critical to
alleviating baby formula shortages in the U.S. and elsewhere, the product being produced once again isn’t expected to be available to consumers for another two weeks. A
February shutdown of the large factory led to supply problems across the U.S.
The shutdown of the Michigan plant has contributed to a
nationwide shortage of infant formula, particularly the more popular Similac that has long been a flagship brand of Abbott’s. The production of EleCare is, however, important because the formula is hypoallergenic and
used by infants and children with gastrointestinal disorders.
